Atıf Formatları
Comparison of Clinicopathological Features and Prognoses in Male and Female Patients with Denovo Metastatic Breast Cancer
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

İ. Doğan Et Al. , "Comparison of Clinicopathological Features and Prognoses in Male and Female Patients with Denovo Metastatic Breast Cancer," San Antonio Breast Cancer Symposium (SABCS) 2025 , Texas, United States Of America, pp.2062, 2025

Doğan, İ. Et Al. 2025. Comparison of Clinicopathological Features and Prognoses in Male and Female Patients with Denovo Metastatic Breast Cancer. San Antonio Breast Cancer Symposium (SABCS) 2025 , (Texas, United States Of America), 2062.

Doğan, İ., Azizy, A., Subaşı, I., Yıldız, İ., Arıcan, A., Yücel, S., ... Dülgeroğlu, O.(2025). Comparison of Clinicopathological Features and Prognoses in Male and Female Patients with Denovo Metastatic Breast Cancer . San Antonio Breast Cancer Symposium (SABCS) 2025 (pp.2062). Texas, United States Of America

Doğan, İzzet Et Al. "Comparison of Clinicopathological Features and Prognoses in Male and Female Patients with Denovo Metastatic Breast Cancer," San Antonio Breast Cancer Symposium (SABCS) 2025, Texas, United States Of America, 2025

Doğan, İzzet Et Al. "Comparison of Clinicopathological Features and Prognoses in Male and Female Patients with Denovo Metastatic Breast Cancer." San Antonio Breast Cancer Symposium (SABCS) 2025 , Texas, United States Of America, pp.2062, 2025

Doğan, İ. Et Al. (2025) . "Comparison of Clinicopathological Features and Prognoses in Male and Female Patients with Denovo Metastatic Breast Cancer." San Antonio Breast Cancer Symposium (SABCS) 2025 , Texas, United States Of America, p.2062.

@conferencepaper{conferencepaper, author={İzzet Doğan Et Al. }, title={Comparison of Clinicopathological Features and Prognoses in Male and Female Patients with Denovo Metastatic Breast Cancer}, congress name={San Antonio Breast Cancer Symposium (SABCS) 2025}, city={Texas}, country={United States Of America}, year={2025}, pages={2062} }